Phospholipase C zeta and oocyte activation defects: moving toward the objective identification of patients eligible for artificial oocyte activation


Like Comment
Related Content

Volume 114, Issue 1, Pages 77–78


Rita Cássia S. Figueira, Ph.D., Sandro C. Esteves, M.D., Ph.D.


Reflections on "The use of phospholipase C zeta (PLCζ) analysis to identify candidates for artificial oocyte activation (AOA): a case series of clinical pregnancies and a proposed algorithm for patient management" by Meng et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.